Intarcia Therapeutics, Inc.
At Intarcia Therapeutics, Inc., employees are the keys to our purpose and success. We unleash our team’s talent, to unlock life’s possibilities for patients with disruptively innovative medicines. Intarcia is a rapidly growing biopharmaceutical company developing innovative therapies that merge medicine and technology. We seek to transform the standard of care and improve patient outcomes in major therapeutic categories for serious chronic diseases, such as diabetes. We successfully completed our Phase 3 clinical trial program and submitted our New Drug Application filing for ITCA 650 in the U.S. in 2016. We are also developing a pipeline of products for our proprietary Medici Drug Delivery System™ comprised of three unique technologies.